Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
This report aims to provide a comprehensive presentation of the global market for Newcastle Disease Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newcastle Disease Vaccine. This report contains market size and forecasts of Newcastle Disease Vaccine in global, including the following market information:
Global Newcastle Disease Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Newcastle Disease Vaccine Market Sales, 2018-2023, 2024-2029, (M Doses)
Global top five Newcastle Disease Vaccine companies in 2022 (%)
The global Newcastle Disease Vaccine market was valued at US$ 323.9 million in 2022 and is projected to reach US$ 402.7 million by 2029, at a CAGR of 3.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology and Yebio, etc. are the leader of this industry. They got about 63% market shares. Asia-Pacific is the largest consumption place, with a consumption market share nearly 56%. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of 2%.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Newcastle Disease Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Newcastle Disease Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Newcastle Disease Vaccine Market Segment Percentages, by Type, 2022 (%)
- Live Vaccines
- Killed Vaccines
Global Newcastle Disease Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Newcastle Disease Vaccine Market Segment Percentages, by Application, 2022 (%)
- Chicken
- Duck & Goose
- Other
Global Newcastle Disease Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Newcastle Disease Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Newcastle Disease Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Newcastle Disease Vaccine revenues share in global market, 2022 (%)
Key companies Newcastle Disease Vaccine sales in global market, 2018-2023 (Estimated), (M Doses)
Key companies Newcastle Disease Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Merial
- CEVA
- QYH Biotech
- Ringpu Biology
- Yebio
- Harbin Veterinary Research Institute
- Merck Animal Health
- DHN
- Zoetis
- ChengDu Tecbond
- Elanco (Lohmann)
- FATRO
- CAVAC
- Vaksindo
Outline of Major Chapters:
Chapter 1: Introduces the definition of Newcastle Disease Vaccine, market overview.
Chapter 2: Global Newcastle Disease Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Newcastle Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Newcastle Disease Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Newcastle Disease Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
Newcastle Disease Vaccine Market, Global Outlook and Forecast 2023-2029
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Newcastle Disease Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Newcastle Disease Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Newcastle Disease Vaccine Overall Market Size
2.1 Global Newcastle Disease Vaccine Market Size: 2022 VS 2029
2.2 Global Newcastle Disease Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Newcastle Disease Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Newcastle Disease Vaccine Players in Global Market
3.2 Top Global Newcastle Disease Vaccine Companies Ranked by Revenue
3.3 Global Newcastle Disease Vaccine Revenue by Companies
3.4 Global Newcastle Disease Vaccine Sales by Companies
3.5 Global Newcastle Disease Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Newcastle Disease Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Newcastle Disease Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Newcastle Disease Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Newcastle Disease Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Newcastle Disease Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Newcastle Disease Vaccine Market Size Markets, 2022 & 2029
4.1.2 Live Vaccines
4.1.3 Killed Vaccines
4.2 By Type - Global Newcastle Disease Vaccine Revenue & Forecasts
4.2.1 By Type - Global Newcastle Disease Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Newcastle Disease Vaccine Revenue, 2024-2029
4.2.3 By Type - Global Newcastle Disease Vaccine Revenue Market Share, 2018-2029
4.3 By Type - Global Newcastle Disease Vaccine Sales & Forecasts
4.3.1 By Type - Global Newcastle Disease Vaccine Sales, 2018-2023
4.3.2 By Type - Global Newcastle Disease Vaccine Sales, 2024-2029
4.3.3 By Type - Global Newcastle Disease Vaccine Sales Market Share, 2018-2029
4.4 By Type - Global Newcastle Disease Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Newcastle Disease Vaccine Market Size, 2022 & 2029
5.1.2 Chicken
5.1.3 Duck & Goose
5.1.4 Other
5.2 By Application - Global Newcastle Disease Vaccine Revenue & Forecasts
5.2.1 By Application - Global Newcastle Disease Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Newcastle Disease Vaccine Revenue, 2024-2029
5.2.3 By Application - Global Newcastle Disease Vaccine Revenue Market Share, 2018-2029
5.3 By Application - Global Newcastle Disease Vaccine Sales & Forecasts
5.3.1 By Application - Global Newcastle Disease Vaccine Sales, 2018-2023
5.3.2 By Application - Global Newcastle Disease Vaccine Sales, 2024-2029
5.3.3 By Application - Global Newcastle Disease Vaccine Sales Market Share, 2018-2029
5.4 By Application - Global Newcastle Disease Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Newcastle Disease Vaccine Market Size, 2022 & 2029
6.2 By Region - Global Newcastle Disease Vaccine Revenue & Forecasts
6.2.1 By Region - Global Newcastle Disease Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Newcastle Disease Vaccine Revenue, 2024-2029
6.2.3 By Region - Global Newcastle Disease Vaccine Revenue Market Share, 2018-2029
6.3 By Region - Global Newcastle Disease Vaccine Sales & Forecasts
6.3.1 By Region - Global Newcastle Disease Vaccine Sales, 2018-2023
6.3.2 By Region - Global Newcastle Disease Vaccine Sales, 2024-2029
6.3.3 By Region - Global Newcastle Disease Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Newcastle Disease Vaccine Revenue, 2018-2029
6.4.2 By Country - North America Newcastle Disease Vaccine Sales, 2018-2029
6.4.3 US Newcastle Disease Vaccine Market Size, 2018-2029
6.4.4 Canada Newcastle Disease Vaccine Market Size, 2018-2029
6.4.5 Mexico Newcastle Disease Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Newcastle Disease Vaccine Revenue, 2018-2029
6.5.2 By Country - Europe Newcastle Disease Vaccine Sales, 2018-2029
6.5.3 Germany Newcastle Disease Vaccine Market Size, 2018-2029
6.5.4 France Newcastle Disease Vaccine Market Size, 2018-2029
6.5.5 U.K. Newcastle Disease Vaccine Market Size, 2018-2029
6.5.6 Italy Newcastle Disease Vaccine Market Size, 2018-2029
6.5.7 Russia Newcastle Disease Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Newcastle Disease Vaccine Market Size, 2018-2029
6.5.9 Benelux Newcastle Disease Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Newcastle Disease Vaccine Revenue, 2018-2029
6.6.2 By Region - Asia Newcastle Disease Vaccine Sales, 2018-2029
6.6.3 China Newcastle Disease Vaccine Market Size, 2018-2029
6.6.4 Japan Newcastle Disease Vaccine Market Size, 2018-2029
6.6.5 South Korea Newcastle Disease Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Newcastle Disease Vaccine Market Size, 2018-2029
6.6.7 India Newcastle Disease Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Newcastle Disease Vaccine Revenue, 2018-2029
6.7.2 By Country - South America Newcastle Disease Vaccine Sales, 2018-2029
6.7.3 Brazil Newcastle Disease Vaccine Market Size, 2018-2029
6.7.4 Argentina Newcastle Disease Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Newcastle Disease Vaccine Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Newcastle Disease Vaccine Sales, 2018-2029
6.8.3 Turkey Newcastle Disease Vaccine Market Size, 2018-2029
6.8.4 Israel Newcastle Disease Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Newcastle Disease Vaccine Market Size, 2018-2029
6.8.6 UAE Newcastle Disease Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merial
7.1.1 Merial Company Summary
7.1.2 Merial Business Overview
7.1.3 Merial Newcastle Disease Vaccine Major Product Offerings
7.1.4 Merial Newcastle Disease Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Merial Key News & Latest Developments
7.2 CEVA
7.2.1 CEVA Company Summary
7.2.2 CEVA Business Overview
7.2.3 CEVA Newcastle Disease Vaccine Major Product Offerings
7.2.4 CEVA Newcastle Disease Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 CEVA Key News & Latest Developments
7.3 QYH Biotech
7.3.1 QYH Biotech Company Summary
7.3.2 QYH Biotech Business Overview
7.3.3 QYH Biotech Newcastle Disease Vaccine Major Product Offerings
7.3.4 QYH Biotech Newcastle Disease Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 QYH Biotech Key News & Latest Developments
7.4 Ringpu Biology
7.4.1 Ringpu Biology Company Summary
7.4.2 Ringpu Biology Business Overview
7.4.3 Ringpu Biology Newcastle Disease Vaccine Major Product Offerings
7.4.4 Ringpu Biology Newcastle Disease Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Ringpu Biology Key News & Latest Developments
7.5 Yebio
7.5.1 Yebio Company Summary
7.5.2 Yebio Business Overview
7.5.3 Yebio Newcastle Disease Vaccine Major Product Offerings
7.5.4 Yebio Newcastle Disease Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Yebio Key News & Latest Developments
7.6 Harbin Veterinary Research Institute
7.6.1 Harbin Veterinary Research Institute Company Summary
7.6.2 Harbin Veterinary Research Institute Business Overview
7.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Major Product Offerings
7.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Harbin Veterinary Research Institute Key News & Latest Developments
7.7 Merck Animal Health
7.7.1 Merck Animal Health Company Summary
7.7.2 Merck Animal Health Business Overview
7.7.3 Merck Animal Health Newcastle Disease Vaccine Major Product Offerings
7.7.4 Merck Animal Health Newcastle Disease Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Merck Animal Health Key News & Latest Developments
7.8 DHN
7.8.1 DHN Company Summary
7.8.2 DHN Business Overview
7.8.3 DHN Newcastle Disease Vaccine Major Product Offerings
7.8.4 DHN Newcastle Disease Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 DHN Key News & Latest Developments
7.9 Zoetis
7.9.1 Zoetis Company Summary
7.9.2 Zoetis Business Overview
7.9.3 Zoetis Newcastle Disease Vaccine Major Product Offerings
7.9.4 Zoetis Newcastle Disease Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Zoetis Key News & Latest Developments
7.10 ChengDu Tecbond
7.10.1 ChengDu Tecbond Company Summary
7.10.2 ChengDu Tecbond Business Overview
7.10.3 ChengDu Tecbond Newcastle Disease Vaccine Major Product Offerings
7.10.4 ChengDu Tecbond Newcastle Disease Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 ChengDu Tecbond Key News & Latest Developments
7.11 Elanco (Lohmann)
7.11.1 Elanco (Lohmann) Company Summary
7.11.2 Elanco (Lohmann) Newcastle Disease Vaccine Business Overview
7.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Major Product Offerings
7.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 Elanco (Lohmann) Key News & Latest Developments
7.12 FATRO
7.12.1 FATRO Company Summary
7.12.2 FATRO Newcastle Disease Vaccine Business Overview
7.12.3 FATRO Newcastle Disease Vaccine Major Product Offerings
7.12.4 FATRO Newcastle Disease Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 FATRO Key News & Latest Developments
7.13 CAVAC
7.13.1 CAVAC Company Summary
7.13.2 CAVAC Newcastle Disease Vaccine Business Overview
7.13.3 CAVAC Newcastle Disease Vaccine Major Product Offerings
7.13.4 CAVAC Newcastle Disease Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 CAVAC Key News & Latest Developments
7.14 Vaksindo
7.14.1 Vaksindo Company Summary
7.14.2 Vaksindo Business Overview
7.14.3 Vaksindo Newcastle Disease Vaccine Major Product Offerings
7.14.4 Vaksindo Newcastle Disease Vaccine Sales and Revenue in Global (2018-2023)
7.14.5 Vaksindo Key News & Latest Developments
8 Global Newcastle Disease Vaccine Production Capacity, Analysis
8.1 Global Newcastle Disease Vaccine Production Capacity, 2018-2029
8.2 Newcastle Disease Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Newcastle Disease Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Newcastle Disease Vaccine Supply Chain Analysis
10.1 Newcastle Disease Vaccine Industry Value Chain
10.2 Newcastle Disease Vaccine Upstream Market
10.3 Newcastle Disease Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Newcastle Disease Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Newcastle Disease Vaccine in Global Market
Table 2. Top Newcastle Disease Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Newcastle Disease Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Newcastle Disease Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Newcastle Disease Vaccine Sales by Companies, (M Doses), 2018-2023
Table 6. Global Newcastle Disease Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Newcastle Disease Vaccine Price (2018-2023) & (USD/K Doses)
Table 8. Global Manufacturers Newcastle Disease Vaccine Product Type
Table 9. List of Global Tier 1 Newcastle Disease Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Newcastle Disease Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type - Global Newcastle Disease Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Newcastle Disease Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Newcastle Disease Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Newcastle Disease Vaccine Sales (M Doses), 2018-2023
Table 15. By Type - Global Newcastle Disease Vaccine Sales (M Doses), 2024-2029
Table 16. By Application - Global Newcastle Disease Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Newcastle Disease Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Newcastle Disease Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Newcastle Disease Vaccine Sales (M Doses), 2018-2023
Table 20. By Application - Global Newcastle Disease Vaccine Sales (M Doses), 2024-2029
Table 21. By Region - Global Newcastle Disease Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Newcastle Disease Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Newcastle Disease Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Newcastle Disease Vaccine Sales (M Doses), 2018-2023
Table 25. By Region - Global Newcastle Disease Vaccine Sales (M Doses), 2024-2029
Table 26. By Country - North America Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Newcastle Disease Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Newcastle Disease Vaccine Sales, (M Doses), 2018-2023
Table 29. By Country - North America Newcastle Disease Vaccine Sales, (M Doses), 2024-2029
Table 30. By Country - Europe Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Newcastle Disease Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Newcastle Disease Vaccine Sales, (M Doses), 2018-2023
Table 33. By Country - Europe Newcastle Disease Vaccine Sales, (M Doses), 2024-2029
Table 34. By Region - Asia Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Newcastle Disease Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Newcastle Disease Vaccine Sales, (M Doses), 2018-2023
Table 37. By Region - Asia Newcastle Disease Vaccine Sales, (M Doses), 2024-2029
Table 38. By Country - South America Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Newcastle Disease Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Newcastle Disease Vaccine Sales, (M Doses), 2018-2023
Table 41. By Country - South America Newcastle Disease Vaccine Sales, (M Doses), 2024-2029
Table 42. By Country - Middle East & Africa Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Newcastle Disease Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Newcastle Disease Vaccine Sales, (M Doses), 2018-2023
Table 45. By Country - Middle East & Africa Newcastle Disease Vaccine Sales, (M Doses), 2024-2029
Table 46. Merial Company Summary
Table 47. Merial Newcastle Disease Vaccine Product Offerings
Table 48. Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 49. Merial Key News & Latest Developments
Table 50. CEVA Company Summary
Table 51. CEVA Newcastle Disease Vaccine Product Offerings
Table 52. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 53. CEVA Key News & Latest Developments
Table 54. QYH Biotech Company Summary
Table 55. QYH Biotech Newcastle Disease Vaccine Product Offerings
Table 56. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 57. QYH Biotech Key News & Latest Developments
Table 58. Ringpu Biology Company Summary
Table 59. Ringpu Biology Newcastle Disease Vaccine Product Offerings
Table 60. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 61. Ringpu Biology Key News & Latest Developments
Table 62. Yebio Company Summary
Table 63. Yebio Newcastle Disease Vaccine Product Offerings
Table 64. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 65. Yebio Key News & Latest Developments
Table 66. Harbin Veterinary Research Institute Company Summary
Table 67. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Offerings
Table 68. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 69. Harbin Veterinary Research Institute Key News & Latest Developments
Table 70. Merck Animal Health Company Summary
Table 71. Merck Animal Health Newcastle Disease Vaccine Product Offerings
Table 72. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 73. Merck Animal Health Key News & Latest Developments
Table 74. DHN Company Summary
Table 75. DHN Newcastle Disease Vaccine Product Offerings
Table 76. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 77. DHN Key News & Latest Developments
Table 78. Zoetis Company Summary
Table 79. Zoetis Newcastle Disease Vaccine Product Offerings
Table 80. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 81. Zoetis Key News & Latest Developments
Table 82. ChengDu Tecbond Company Summary
Table 83. ChengDu Tecbond Newcastle Disease Vaccine Product Offerings
Table 84. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 85. ChengDu Tecbond Key News & Latest Developments
Table 86. Elanco (Lohmann) Company Summary
Table 87. Elanco (Lohmann) Newcastle Disease Vaccine Product Offerings
Table 88. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 89. Elanco (Lohmann) Key News & Latest Developments
Table 90. FATRO Company Summary
Table 91. FATRO Newcastle Disease Vaccine Product Offerings
Table 92. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 93. FATRO Key News & Latest Developments
Table 94. CAVAC Company Summary
Table 95. CAVAC Newcastle Disease Vaccine Product Offerings
Table 96. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 97. CAVAC Key News & Latest Developments
Table 98. Vaksindo Company Summary
Table 99. Vaksindo Newcastle Disease Vaccine Product Offerings
Table 100. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2018-2023)
Table 101. Vaksindo Key News & Latest Developments
Table 102. Newcastle Disease Vaccine Production Capacity (M Doses) of Key Manufacturers in Global Market, 2021-2023 (M Doses)
Table 103. Global Newcastle Disease Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 104. Global Newcastle Disease Vaccine Production by Region, 2018-2023 (M Doses)
Table 105. Global Newcastle Disease Vaccine Production by Region, 2024-2029 (M Doses)
Table 106. Newcastle Disease Vaccine Market Opportunities & Trends in Global Market
Table 107. Newcastle Disease Vaccine Market Drivers in Global Market
Table 108. Newcastle Disease Vaccine Market Restraints in Global Market
Table 109. Newcastle Disease Vaccine Raw Materials
Table 110. Newcastle Disease Vaccine Raw Materials Suppliers in Global Market
Table 111. Typical Newcastle Disease Vaccine Downstream
Table 112. Newcastle Disease Vaccine Downstream Clients in Global Market
Table 113. Newcastle Disease Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Newcastle Disease Vaccine Segment by Type in 2022
Figure 2. Newcastle Disease Vaccine Segment by Application in 2022
Figure 3. Global Newcastle Disease Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Newcastle Disease Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Newcastle Disease Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Newcastle Disease Vaccine Sales in Global Market: 2018-2029 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Newcastle Disease Vaccine Revenue in 2022
Figure 9. By Type - Global Newcastle Disease Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Newcastle Disease Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Newcastle Disease Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Newcastle Disease Vaccine Price (USD/K Doses), 2018-2029
Figure 13. By Application - Global Newcastle Disease Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Newcastle Disease Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Newcastle Disease Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Newcastle Disease Vaccine Price (USD/K Doses), 2018-2029
Figure 17. By Region - Global Newcastle Disease Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Newcastle Disease Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Newcastle Disease Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Newcastle Disease Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Newcastle Disease Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Newcastle Disease Vaccine Sales Market Share, 2018-2029
Figure 23. US Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Newcastle Disease Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Newcastle Disease Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Newcastle Disease Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Newcastle Disease Vaccine Sales Market Share, 2018-2029
Figure 37. China Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Newcastle Disease Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Newcastle Disease Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Newcastle Disease Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Newcastle Disease Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Newcastle Disease Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Newcastle Disease Vaccine Production Capacity (M Doses), 2018-2029
Figure 53. The Percentage of Production Newcastle Disease Vaccine by Region, 2022 VS 2029
Figure 54. Newcastle Disease Vaccine Industry Value Chain
Figure 55. Marketing Channels
Global Classical Swine Fever Vaccines Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 100
It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).
The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......
Global Tylosin Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 96
According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period.
The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......
Global Animal Parasiticides Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 106
According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period.
The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......
Global Newcastle Disease Vaccine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 114
According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period.
The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......
Global Classical Swine Fever Vaccines Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 126
According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period.
The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......
Global Veterinary Vaccine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 151
According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period.
The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......
Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 134
According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period.
The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......
Global Veterinary Products for Companion Animals Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 109
According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period.
The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......
Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 115
According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period.
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
